selenious acid has been researched along with Huntington Disease in 1 studies
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, Z | 1 |
| Marks, E | 1 |
| Chen, J | 1 |
| Moline, J | 1 |
| Barrows, L | 1 |
| Raisbeck, M | 1 |
| Volitakis, I | 1 |
| Cherny, RA | 1 |
| Chopra, V | 1 |
| Bush, AI | 1 |
| Hersch, S | 1 |
| Fox, JH | 1 |
1 other study available for selenious acid and Huntington Disease
| Article | Year |
|---|---|
Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
Topics: Adult; Animals; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Human | 2014 |